The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Ziconotide: a review of its pharmacology and use in the treatment of pain
Open accessAbstract
Ziconotide is a powerful analgesic drug that has a unique mechanism of action involving potent and selective block of N-type calcium channels, which control neurotransmission at many synapses. The analgesic efficacy of ziconotide likely results from its ability to interrupt pain signaling at the level of the spinal cord. Ziconotide is a peptidic drug and has been approved for the treatment of severe chronic pain in patients only when administered by the intrathecal route. Importantly, prolonged administration of ziconotide does not lead to the development of addiction or tolerance. The current review discusses the various studies that have addressed the in vitro biochemical and electrophysiological actions of ziconotide as well as the numerous pre-clinical studies that were conducted to elucidate its antinociceptive mechanism of action in animals. In addition, this review considers the pivotal Phase 3 (and other) clinical trials that were conducted in support of ziconotide's approval for the treatment of severe chronic pain and tries to offer some insights regarding the future discovery and development of newer analgesic drugs that would act by a similar mechanism to ziconotide but which might offer improved safety, tolerability and ease of use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Human brain mechanisms of pain perception and regulation in health and disease
Apkarian, A. V., Bushnell, M. C., Treede, R., & Zubieta, J. (2005) · European Journal of Pain · doi:10.1016/j.ejpain.2004.11.001 · Cited by 3,126
Nomenclature of Voltage-Gated Sodium Channels
Goldin, A. L., Barchi, R. L., Caldwell, J. H., Hofmann, F., Howe, J. R., Hunter, J. C., Kallen, R. G., Mandel, G., Meisler, M. H., Netter, Y. B., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)00116-1 · Cited by 1,481
Roles of N-Type and Q-Type Ca 2+ Channels in Supporting Hippocampal Synaptic Transmission
Wheeler, D. B., Randall, A., & Tsien, R. W. (1994) · Science · doi:10.1126/science.7832825 · Cited by 949
Nomenclature of Voltage-Gated Calcium Channels
Ertel, E. A., Campbell, K. P., Harpold, M. M., Hofmann, F., Mori, Y., Perez-Reyes, E., Schwartz, A., Snutch, T. P., Tanabe, T., Birnbaumer, L., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)81057-0 · Cited by 885
Light, A. R., & Perl, E. R. (1979) · Journal of Comparative Neurology · doi:10.1002/cne.901860203 · Cited by 799
Staats, P. S., Yearwood, T., Charapata, S. G., Presley, R. W., Wallace, M. S., Byas-Smith, M., Fisher, R., Bryce, D. A., Mangieri, E. A., Luther, R. R., et al. (2004) · JAMA · doi:10.1001/jama.291.1.63 · Cited by 654
Watkins, P. B., Kaplowitz, N., Slattery, J. T., Colonese, C. R., Colucci, S. V., Stewart, P. W., & Harris, S. C. (2006) · JAMA · doi:10.1001/jama.296.1.87 · Cited by 632
Luo, Z. D., Chaplan, S. R., Higuera, E. S., Sorkin, L. S., Stauderman, K. A., Williams, M. E., & Yaksh, T. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01868.2001 · Cited by 616
Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain
Miljanich, G. P. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043363884 · Cited by 607
Gutman, G. A., Chandy, K. G., Adelman, J. P., Aiyar, J., Bayliss, D. A., Clapham, D. E., Covarriubias, M., Desir, G. V., Furuichi, K., Ganetzky, B., et al. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.9 · Cited by 583
Dickenson, A. H., & Sullivan, A. F. (1987) · Pain · doi:10.1016/0304-3959(87)90023-6 · Cited by 536
Calcium control of transmitter release at a cerebellar synapse
Mintz, I. M., Sabatini, B. L., & Regehr, W. G. (1995) · Neuron · doi:10.1016/0896-6273(95)90155-8 · Cited by 525
Haley, J. E., & Dickenson, A. H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.001 · Cited by 511
Auxiliary subunits: essential components of the voltage-gated calcium channel complex
Arikkath, J., & Campbell, K. P. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00066-7 · Cited by 505
A new conus peptide ligand for mammalian presynaptic Ca2+ channels
Hillyard, D. R., Monje, V. D., Mintz, I. M., Bean, B. P., Nadasdi, L., Ramachandran, J., Miljanich, G., Azimi-Zoonooz, A., McIntosh, J. M., Cruz, L. J., et al. (1992) · Neuron · doi:10.1016/0896-6273(92)90221-x · Cited by 488
Peptides and the primary afferent nociceptor
Levine, J., Fields, H., & Basbaum, A. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02273.1993 · Cited by 485
Light, A. R., & Perl, E. R. (1979) · Journal of Comparative Neurology · doi:10.1002/cne.901860202 · Cited by 467
Haley, J. E., Sullivan, A. F., & Dickenson, A. H. (1990) · Brain Research · doi:10.1016/0006-8993(90)90975-h · Cited by 460
Afferent pain pathways: a neuroanatomical review
Almeida, T. F., Roizenblatt, S., & Tufik, S. (2004) · Brain Research · doi:10.1016/j.brainres.2003.10.073 · Cited by 446
Immune and glial cell factors as pain mediators and modulators
McMahon, S. B., Cafferty, W. B. J., & Marchand, F. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.001 · Cited by 445
Dickenson, A. H., Chapman, V., & Green, G. M. (1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00359-x · Cited by 399
Light, A. R., Trevino, D. L., & Perl, E. R. (1979) · Journal of Comparative Neurology · doi:10.1002/cne.901860204 · Cited by 380
Localization of Ca2+Channel Subtypes on Rat Spinal Motor Neurons, Interneurons, and Nerve Terminals
Westenbroek, R. E., Hoskins, L., & Catterall, W. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06319.1998 · Cited by 377
Presynaptic calcium and control of vesicle fusion
Schneggenburger, R., & Neher, E. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.006 · Cited by 340
Llinás, R., Sugimori, M., Hillman, D. E., & Cherksey, B. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90053-b · Cited by 332
Rauck, R. L., Wallace, M. S., Leong, M. S., MineHart, M., Webster, L. R., Charapata, S. G., Abraham, J. E., Buffington, D. E., Ellis, D., Kartzinel, R., et al. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.10.003 · Cited by 306
Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia.
Chaplan, S. R., Pogrel, J. W., & Yaksh, T. L. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38848-8 · Cited by 299
Malmberg, A., & Yaksh, T. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04882.1994 · Cited by 288
Bowersox, S. S., Gadbois, T., Singh, T., Pettus, M., Wang, Y. X., & Luther, R. R. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21283-6 · Cited by 274
Update on the Neurophysiology of Pain Transmission and Modulation
Bennett, G. J. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00120-7 · Cited by 270
Porreca, F., Burgess, S. E., Gardell, L. R., Vanderah, T. W., Malan, T. P., Ossipov, M. H., Lappi, D. A., & Lai, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05281.2001 · Cited by 266
Spinal and Supraspinal Mechanisms of Neuropathic Pain
OSSIPOV, M. H., LAI, J., MALAN, T. P., & PORRECA, F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06673.x · Cited by 265
Dickenson, A. H., & Sullivan, A. F. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90242-4 · Cited by 264
Permeation and Selectivity in Calcium Channels
Sather, W. A., & McCleskey, E. W. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142345 · Cited by 258
Opioid receptor types and membrane ion channels
Alan North, R. (1986) · Trends in Neurosciences · doi:10.1016/0166-2236(86)90038-x · Cited by 249
Cell-Specific Alternative Splicing Increases Calcium Channel Current Density in the Pain Pathway
Bell, T. J., Thaler, C., Castiglioni, A. J., Helton, T. D., & Lipscombe, D. (2004) · Neuron · doi:10.1016/s0896-6273(03)00801-8 · Cited by 233
International Union of Pharmacology. XL. Compendium of Voltage-Gated Ion Channels: Calcium Channels
Catterall, W. A., Striessnig, J., Snutch, T. P., & Perez-Reyes, E. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.8 · Cited by 230
Newton, R. A., Bingham, S., Case, P. C., Sanger, G. J., & Lawson, S. N. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00188-7 · Cited by 226
Wallace, M. S., Charapata, S. G., Fisher, R., Byas-Smith, M., Staats, P. S., Mayo, M., McGuire, D., & Ellis, D. (2006) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/j.1525-1403.2006.00055.x · Cited by 209
Matthews, E. A., & Dickenson, A. H. (2001) · Pain · doi:10.1016/s0304-3959(01)00255-x · Cited by 197
Lin, Z., Haus, S., Edgerton, J., & Lipscombe, D. (1997) · Neuron · doi:10.1016/s0896-6273(01)80054-4 · Cited by 190
Smith, M. T., Cabot, P. J., Ross, F. B., Robertson, A. D., & Lewis, R. J. (2002) · Pain · doi:10.1016/s0304-3959(01)00436-5 · Cited by 178
Scott, D. A., Wright, C. E., & Angus, J. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02247-1 · Cited by 177
Reciprocal regulation of P/Q-type Ca2+ channels by SNAP-25, syntaxin and synaptotagmin
Zhong, H., Yokoyama, C. T., Scheuer, T., & Catterall, W. A. (1999) · Nature Neuroscience · doi:10.1038/14721 · Cited by 167
Calcium Channels As Therapeutic Targets in Neuropathic Pain
Yaksh, T. L. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.09.007 · Cited by 165
Wang, Y., Gao, D., Pettus, M., Phillips, C., & Bowersox, S. S. (2000) · Pain · doi:10.1016/s0304-3959(99)00214-6 · Cited by 161
Olsen, H. L., Theander, S., Bokvist, K., Buschard, K., Wollheim, C. B., & Gromada, J. (2005) · Endocrinology · doi:10.1210/en.2005-0800 · Cited by 156
Díaz, Á., & Dickenson, A. H. (1997) · Pain · doi:10.1016/s0304-3959(96)03271-x · Cited by 154
Čížková, D., Mars̆ala, J., Lukáčová, N., Maršala, M., Jergová, S., Orendáčová, J., & Yaksh, T. L. (2002) · Experimental Brain Research · doi:10.1007/s00221-002-1217-3 · Cited by 148
Targeting N-type and T-type calcium channels for the treatment of pain
McGivern, J. G. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03662-7 · Cited by 133
Self-citationSynthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats.
Xiao, W. H., & Bennett, G. J. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10579-x · Cited by 131
Gohil, K., BELL, J. R., Ramachandran, J., & Miljanich, G. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)90398-0 · Cited by 116
Gasparini, S., Kasyanov, A. M., Pietrobon, D., Voronin, L. L., & Cherubini, E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08715.2001 · Cited by 114
Regulation of Presynaptic Calcium Channels by Synaptic Proteins
Zamponi, G. W. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.92.79 · Cited by 111
Pharmacokinetics and Pharmacodynamics of Intrathecal Ziconotide in Chronic Pain Patients
Wermeling, D. P., Drass, M., Ellis, D., Mayo, M. R., McGuire, D., O’Connell, D. P., Hale, V. G., & Chao, S. T. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003043006008 · Cited by 91
An evaluation of intrathecal ziconotide for the treatment of chronic pain
Jain, K. K. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.10.2403 · Cited by 90
Lin, Z., Lin, Y., Schorge, S., Pan, J. Q., Beierlein, M., & Lipscombe, D. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05322.1999 · Cited by 90
Feng, Z., Hamid, J., Doering, C. J., Bosey, G. M., Snutch, T. P., & Zamponi, G. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100406200 · Cited by 88
Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain
Winquist, R. J., Pan, J. Q., & Gribkoff, V. K. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.035 · Cited by 85
Gaur, S., Newcomb, R., Rivnay, B., BELL, J. R., Yamashiro, D., Ramachandran, J., & Miljanich, G. P. (1994) · Neuropharmacology · doi:10.1016/s0028-3908(05)80012-7 · Cited by 83
Castiglioni, A. J., Raingo, J., & Lipscombe, D. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.115030 · Cited by 81
How do G proteins directly control neuronal Ca2+ channel function?
WAARD, M. M. D., Hering, J., Weiss, N., & Feltz, A. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.06.008 · Cited by 77
Pan, J. Q., & Lipscombe, D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-13-04769.2000 · Cited by 66
Abe, M., Kurihara, T., Han, W., Shinomiya, K., & Tanabe, T. (2002) · Spine · doi:10.1097/00007632-200207150-00007 · Cited by 64
Katz, W. A., & Rothenberg, R. (2005) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000158686.43637.af · Cited by 63
Nebe, J., Vanegas, H., Neugebauer, V., & Schaible, H. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01386.x · Cited by 62
Bioavailability of Ziconotide in brain: influx from blood, stability, and diffusion
Newcomb, R., Abbruscato, T. J., Singh, T., Nádasdi, L., Davis, T. P., & Miljanich, G. P. (2000) · Peptides · doi:10.1016/s0196-9781(00)00175-3 · Cited by 55
Roles of Individual Disulfide Bonds in the Stability and Folding of an ω-Conotoxin
Price-Carter, M. L., Hull, M. S., & Goldenberg, D. P. (1998) · Biochemistry · doi:10.1021/bi9803978 · Cited by 54
SNX-325, a novel calcium antagonist from the spider Segestria florentina
Newcomb, R., Palma, A., Fox, J. A., Gaur, S., Lau, K., Chung, D., Cong, R., BELL, J. R., & Horne, B. E. (1995) · Biochemistry · doi:10.1021/bi00026a015 · Cited by 53
Ziconotide Infusion for Severe Chronic Pain: Case Series of Patients with Neuropathic Pain
Wermeling, D. P., & Berger, J. R. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.3.395 · Cited by 37
Sher, E., Giovannini, F., Codignola, A., Passafaro, M., Giorgi-Rossi, P., Volsen, S. G., Craig, P. J., Davalli, A. M., & Carrera, P. (2003) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000008032.49504.48 · Cited by 33
Fox, J. A. (1995) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00374813 · Cited by 20
Increased glucose tolerance in N-type Ca2+ channel α1B-subunit gene-deficient mice
Takahashi, E., Ito, M., Miyamoto, N., Nagasu, T., Ino, M., & Tanaka, I. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.15.6.937 · Cited by 19
Cited by
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Etiology and Pharmacology of Neuropathic Pain
Alles, S. R. A., & Smith, P. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014399 · Cited by 395
Cyclic peptide drugs approved in the last two decades (2001–2021)
Zhang, H., & Chen, S. (2022) · RSC Chemical Biology · doi:10.1039/d1cb00154j · Cited by 319
Metadata
- Authors
- McGivern, J. G.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2007-02
- Volume
- 3
- Issue
- 1
- Pages
- 69-85
- ISSN
- 1176-6328 (ISSN-L)
- OpenAlex
- W1999893599
- Cited by
- 310
- References
- 74
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.